Vir Biotechnology, Inc.

VIR - CIK 0001706431

Market cap$1.39 B

Rank#2396

SEC filings762

VIR balance sheet (annual)

The table below shows Vir Biotechnology, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$232.19M	$222.95M	$241.58M	$848.63M	$347.81M	$436.57M
Short-term investments	$228.75M	$678.05M	$1.27B	$1.52B	$217.18M	$300.29M
Receivables	-	-	-	$0.00	$773.08M	-
Inventory	-	-	-	-	-	-

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.